Cryoport Supports Opexa Therapeutics' Lead Personalized T-Cell Immunotherapy Programs
August 26, 2015 at 08:31 AM EDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company"), the leading provider of advanced cryogenic logistics solutions for the life sciences ...